Matthew focuses on rare neurodevelopmental disorders including Rett syndrome, Dravet syndrome, and congenital disorders of glycosylation. With more than a decade of research experience in genetics, molecular biology, and epigenetics, he leads programs from novel model development and characterization through IND-enabling therapeutic studies. Matthew is passionate about partnering with advocacy groups and families to advance therapies for children with rare diseases.
Matthew received his dual B.S. in molecular biology and biochemistry from the Florida Institute of Technology. Matthew then studied germ cell immortality in Caenorhabditis elegans at the UNC School of Medicine for his graduate and postdoctoral work. Matthew completed an additional postdoctoral research fellowship at the University of Rochester before joining the JAX Rare Disease Translational Center as a Senior Study Director.